Japanese Society of Nephrology

わが国では2014年に改訂された糖尿病性腎症病期分類が広く用いられてきた．最近では，高齢化や肥満者の増加，糖尿病や高血圧症に対する新規治療薬の開発などを背景に，糖尿病患者に合併した腎臓病が多様化していることが指摘されている．そこで糖尿病性腎症合同委員会では，腎症病期分類を再度改訂する必要性を検討した．現時点では，アルブミン尿や推算糸球体濾過量に基づく2014年分類を変更する必要性を示唆する新たなエビデンスが発出されていないことから，今回の改訂では2014年分類の基本的な枠組みは変更しないこととした．ただし，日本腎臓学会のCKD重症度分類や国際的な表記との整合性を重視し，病期名を「正常アルブミン尿期（第1期）」，「微量アルブミン尿期（第2期）」，「顕性アルブミン尿期（第3期）」，「GFR高度低下・末期腎不全期（第4期）」，「腎代替療法期（第5期）」へ変更した．

BackgroundRecent clinical reports indicate a correlation between new-onset and relapse of nephrotic syndrome (NS) following coronavirus 2019 (COVID-19) vaccination in patients with glomerular diseases. However, there are no reports of a nationwide survey on NS following COVID-19 vaccination in Japan.MethodsWe conducted a web-based survey of council members of the Japanese Society of Nephrology (581 members, 382 facilities) to elucidate the relationship between COVID-19 vaccination and new-onset and relapse of NS.ResultsFollowing COVID-19 vaccination, 27 patients (male: 15, 55.6%) with new-onset (n = 6) and relapse (n = 21) of NS were reported. Of them, 12 (44.4%) patients were diagnosed with minimal change disease at the occurrence of NS. Five patients developed a slight increase in serum creatinine levels; however, none progressed to severe renal dysfunction.ConclusionOur findings clarify the clinical features of new-onset and relapse of NS following COVID-19 vaccination. Although there was no obvious progression to severe renal dysfunction, clinicians and pathologists should be aware that NS is a potential adverse effect of the vaccines.

Tokyo Medical and Dental University (TMDU) received unrestricted research grants for the Department of Lifetime Clinical Immunology from AbbVie GK, Ayumi Pharmaceutical Corporation, Chugai Pharmaceutical Co., Ltd., CSL Behring K.K., Japan Blood Products Organization, Nippon Kayaku Co., Ltd., UCB Japan Co. Ltd., Asahikasei Pharmaceutical Corporation, with which TMDU paid the salary of Masaaki Mori. All other authors declare no conflicts of interest.

ISAKA Y

2012年度及び2016年度に行われた日本内科学会と内科系13学会における男女共同参画の実態調査結果を比較した．女性理事のいる学会が5学会から9学会に増加し，女性評議員数も全学会で増加，男女共同参画推進組織のある学会は10学会から13学会となった．評議員，委員会委員，司会・座長の女性の比率がいずれも会員比と同等の学会は2016年度で1学会のみであったのに対し，専門医の女性比率は13学会で会員比とほぼ同等であった．

NeuropathologyVolume 18, Issue 3 p. 353-354 PREPARING MANUSCRIPTS ABOUT NEUROPATHOLOGY IN ENGLISH: A SUGGESTED APPROACH Henry deF Webster MD, Japanese Society of Neuropathology, 29/5/98, Fukuoka, JapanSearch for more papers by this author Henry deF Webster MD, Japanese Society of Neuropathology, 29/5/98, Fukuoka, JapanSearch for more papers by this author First published: 21 May 2007 https://doi.org/10.1111/j.1440-1789.1998.tb00128.xAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinked InRedditWechat No abstract is available for this article. Volume18, Issue3September 1998Pages 353-354 RelatedInformation